Healthcare provider profile · identity verified

Joseph Tabb Standard, MD

Family Practice · DAVENPORT, IA · NPI 1609360205

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	557	160
Atorvastatin Calcium	Atorvastatin Calcium	531	154
Pantoprazole Sodium	Pantoprazole Sodium	333	96
Levothyroxine Sodium	Levothyroxine Sodium	328	80
Lisinopril	Lisinopril	314	93
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	307	62
Losartan Potassium	Losartan Potassium	279	80
Sertraline Hcl	Sertraline Hcl	260	58
Alprazolam	Alprazolam	251	51
Gabapentin	Gabapentin	247	58
Metoprolol Succinate	Metoprolol Succinate	238	76
Tramadol Hcl	Tramadol Hcl	237	44
Hydrochlorothiazide	Hydrochlorothiazide	231	67
Omeprazole	Omeprazole	225	69
Pravastatin Sodium	Pravastatin Sodium	224	70
Metformin Hcl	Metformin Hcl	212	66
Famotidine	Famotidine	192	66
Eliquis	Apixaban	190	34
Albuterol Sulfate Hfa	Albuterol Sulfate	186	60
Furosemide	Furosemide	182	54
Trazodone Hcl	Trazodone Hcl	170	48
Potassium Chloride	Potassium Chloride	163	46
Buspirone Hcl	Buspirone Hcl	148	29
Duloxetine Hcl	Duloxetine Hcl	147	24
Metoprolol Tartrate	Metoprolol Tartrate	143	36
Rosuvastatin Calcium	Rosuvastatin Calcium	136	42
Tamsulosin Hcl	Tamsulosin Hcl	129	39
Montelukast Sodium	Montelukast Sodium	125	32
Lorazepam	Lorazepam	113	21
Meloxicam	Meloxicam	110	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	108	27
Simvastatin	Simvastatin	99	34
Allopurinol	Allopurinol	95	29
Clonazepam	Clonazepam	94	15
Clopidogrel	Clopidogrel Bisulfate	92	29
Fluticasone Propionate	Fluticasone Propionate	92	41
Zolpidem Tartrate	Zolpidem Tartrate	89	22
Citalopram Hbr	Citalopram Hydrobromide	74	16
Mirtazapine	Mirtazapine	72	15
Carvedilol	Carvedilol	70	20
Bupropion Xl	Bupropion Hcl	68	19
Ezetimibe	Ezetimibe	65	24
Escitalopram Oxalate	Escitalopram Oxalate	64	19
Ozempic	Semaglutide	61	16
Lovastatin	Lovastatin	60	16
Pregabalin	Pregabalin	60	13
Spironolactone	Spironolactone	58	16
Triamcinolone Acetonide	Triamcinolone Acetonide	56	30
Prednisone	Prednisone	54	25
Metformin Hcl Er	Metformin Hcl	52	18
Tizanidine Hcl	Tizanidine Hcl	51	13
Paroxetine Hcl	Paroxetine Hcl	49	12
Fluoxetine Hcl	Fluoxetine Hcl	47	16
Warfarin Sodium	Warfarin Sodium	46	14
Glipizide	Glipizide	45	15
Hydroxyzine Hcl	Hydroxyzine Hcl	45	13
Myrbetriq	Mirabegron	45	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	39
Donepezil Hcl	Donepezil Hcl	43	suppressed
Januvia	Sitagliptin Phosphate	43	12
Jardiance	Empagliflozin	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	38	suppressed
Bupropion Hcl Sr	Bupropion Hcl	37	12
Fentanyl	Fentanyl	37	suppressed
Atenolol	Atenolol	35	13
Baclofen	Baclofen	35	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	35	suppressed
Fenofibrate	Fenofibrate	34	suppressed
Glipizide Er	Glipizide	34	11
Fenofibrate	Fenofibrate Nanocrystallized	33	11
Ondansetron Odt	Ondansetron	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Xarelto	Rivaroxaban	33	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Spiriva Respimat	Tiotropium Bromide	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Cephalexin	Cephalexin	30	27
Celecoxib	Celecoxib	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cefuroxime	Cefuroxime Axetil	24	20
Fluconazole	Fluconazole	24	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	14
Doxycycline Hyclate	Doxycycline Hyclate	23	18
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	19
Finasteride	Finasteride	19	11
Irbesartan	Irbesartan	19	suppressed
Ketoconazole	Ketoconazole	19	14
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Mirabegron Er	Mirabegron	17	suppressed
Ramipril	Ramipril	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Azithromycin	Azithromycin	16	13
Benazepril Hcl	Benazepril Hcl	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	12
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amoxicillin	Amoxicillin	15	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Valsartan	Valsartan	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Cefdinir	Cefdinir	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Carisoprodol	Carisoprodol	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nystatin	Nystatin	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Colchicine	Colchicine	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Keveyis	Dichlorphenamide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error